Liz Highleyman, Author at San Francisco AIDS Foundation

Liz Highleyman

Liz Highleyman

Liz Highleyman is a medical journalist and science editor for POZ magazine.

Research

As 2026 Gets Underway, What’s in the Pipeline for HIV Prevention and Treatment?

PrEP

FDA Approves Twice-Yearly Lenacapavir for PrEP

stock photo of vials of clear liquid and syringe

PrEP

Lenacapavir Looks Promising for Once-Yearly PrEP

Advocacy

Researchers and Advocates Rally Together to Defend HIV Funding and “Save Our Sciences”

PrEP

Twice-yearly injectable PrEP is highly effective for gay men and trans individuals

Patient wearing a black T shirt sits in a chair at SFAF's Magnet clinic, accompanied by a clinician standing off to the side

PrEP

Digging into the science–and promise–of long-acting injectable PrEP

PrEP

Injectable PrEP Is Here. What Does This Mean for You?

PrEP

Injectable PrEP Offers a New Option for Women

Prevention

Hormone levels not affected by PrEP in trans women

PrEP

PrEP scales up, HIV incidence declines

Research

CROI 2018: A roundup of the most exciting PrEP news & research

PrEP

New research at CROI 2016: How PrEP changes kidney function

Prevention

Just How Risky Is It? Studies Shed Light on HIV Risk and Prevention

medical images

Research

A Guide to Clinical Trials: Understanding Clinical Studies

Showing posts 1 – 14 of 14